{"abstract": "Use of the anemia drugs will be reviewed by federal health insurance programs because of concerns that side effects may be harming patients.", "web_url": "https://www.nytimes.com/2007/03/15/business/15amgen.html", "snippet": "Use of the anemia drugs will be reviewed by federal health insurance programs because of concerns that side effects may be harming patients.", "lead_paragraph": "Use of the anemia drugs Aranesp and Epogen, made by Amgen, and Procrit, from Johnson & Johnson, will be reviewed by federal health insurance programs because of concerns that side effects may be harming patients.", "print_section": "C", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "U.S. to Review Anemia Drugs for Safety", "kicker": null, "content_kicker": null, "print_headline": "U.S. to Review Anemia Drugs For Safety", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "ANEMIA", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson Inc", "rank": 3, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}], "pub_date": "2007-03-15T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Bloomberg News", "person": [{"firstname": "Bloomberg", "middlename": null, "lastname": "News", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/379e367c-2c79-58c8-b355-b87b4248f9a7", "word_count": 260, "uri": "nyt://article/379e367c-2c79-58c8-b355-b87b4248f9a7"}